Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Otolaryngeal Cancer × Ketamine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 2 Neoplasms 2 Gastrointestinal Neoplasms 2 Depression 2 Anxiety Disorders 2 Peripheral Nervous System Diseases 1 Otolaryngeal Cancer 1 Neurotoxicity Syndromes 1 Lung Neoplasms 1 Cancer Pain 1 Acute Pain 1

Interventions

Saline Solution 1 Ketamine 1 Electroencephalography 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03040024 2021-07-08

Delirium Prevention With Ketamine in Ear, Nose, and Throat (ENT) Patients

Emory University

Phase 4 Terminated

71 enrolled 17 charts

Otolaryngeal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡